INAB Kacepetan wutah bathi saben saham ing taun lumaku IN8bio Inc

INAB (IN8bio, Inc.) - tandha merek perusahaan

The complexity of manual cell modification limits the scaling of IN8bio, Inc. (INAB), which correlates with the annual earnings per share trend. Risks are linked to the experimental nature of the therapy and development costs, while the stability of the R&D core ensures human capital potential. The current 74.10 metric indicates the yield status, helping to determine the historical extremes of the business's fundamental valuation.

INAB - Wutah bathi ing taun lumaku IN8bio, Inc ing rentang 04.07.2022 - 14.11.2026

Ringkesan rincian data analitis in8bio.com (INAB)

- nilai saham lan prakiraan konsensus rega:
Rega bursa IN8bio Inc|INAB - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar IN8bio|INAB - Nilai Perusahaan
- data ekuitas miturut neraca:
Ekuitas saben Saham IN8bio|INAB - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku in8bio.com|INAB - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Utang marang Ekuitas IN8bio, Inc.|INAB - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal IN8bio Inc.|INAB - Utang perusahaan|Utang-utang marang kapitalisasi buku IN8bio, Inc|INAB - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan IN8bio|Indikator likuiditas cepet in8bio.com
- statistik bathi lan rasio pasar:
INAB - Bathi pungkasan|Proyeksi bathi mangsa ngarep IN8bio, Inc.|INAB - Periode bali modal bisnis|Rega marang bathi mangsa ngarep IN8bio Inc.|INAB - Rasio P/E diaturake wutah|Pangali EV/EBITDA IN8bio Inc.|INAB - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan IN8bio|INAB - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan in8bio.com|INAB - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep IN8bio, Inc.
- informasi babagan volume dodolan lan pendapatan:
INAB - Volume dodolan perusahaan|Prakiraan volume dodolan IN8bio, Inc|INAB - Multiplikator P/S|Multiplikator Forward P/S IN8bio, Inc.
Analisis dhasar perusahaan:IN8bio, Inc.
Produk merek IN8bio, Inc.

The stability of IN8bio, Inc. (INAB) is ensured by strict compliance with environmental regulations when handling reagents within clinical trials. This factor correlates with the dynamics of net earnings per share, measuring the percentage deviation of the current result from the previous year's figures. Analyzing the annual EPS growth rate allows for an assessment of the business recovery pace, although it requires comparison with the debt load to minimize risks.

Analisis pesaing IN8bio, Inc.

Kacepetan wutah bathi saben saham ing taun lumaku TG Pharma (TGTX)|Wutah bathi saben saham ing taun lumaku Arcellx Inc|Kacepetan wutah bathi saben saham ing taun lumaku Disc Medicine, Inc. IRON|Wutah bathi ing taun lumaku SNDX|Kura Oncology Inc - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ADCT (ADC Therapeutics S.A.)|FHTX (Foghorn Therapeutics) - Dinamika bathi saben saham ing taun lumaku|VOR - Wutah bathi saben saham ing taun lumaku|NKTX - Wutah bathi ing taun lumaku|COEP: Wutah bathi ing taun lumaku|ATNM: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Estrella Bio|CASI Pharmaceuticals, Inc. (CASI) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku MRKR|Eterna Therapeutics Inc. - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku GT Biopharma Corporation GTBP|aptose.com (APTO) - Kacepetan wutah bathi saben saham ing taun lumaku|BPTH: Wutah bathi resik saben saham ing taun iki|MEIP - Wutah bathi ing taun lumaku|VINC (Vincerx) - Wutah bathi resik saben saham ing taun iki